These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24877660)

  • 1. Effect of whole soy and purified isoflavone daidzein on renal function--a 6-month randomized controlled trial in equol-producing postmenopausal women with prehypertension.
    Liu ZM; Ho SC; Chen YM; Tang N; Woo J
    Clin Biochem; 2014 Sep; 47(13-14):1250-6. PubMed ID: 24877660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A six-month randomized controlled trial of whole soy and isoflavones daidzein on body composition in equol-producing postmenopausal women with prehypertension.
    Liu ZM; Ho SC; Chen YM; Woo J
    J Obes; 2013; 2013():359763. PubMed ID: 23984051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function--a 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension.
    Liu ZM; Ho SC; Chen YM; Tomlinson B; Ho S; To K; Woo J
    Eur J Clin Nutr; 2015 Oct; 69(10):1161-8. PubMed ID: 25782428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
    Liu ZM; Ho SC; Woo J; Chen YM; Wong C
    Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Ho S; To K; Tomlinson B; Woo J
    Mol Nutr Food Res; 2014 Apr; 58(4):709-17. PubMed ID: 24273218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of whole soy and purified daidzein on androgenic hormones in chinese equol-producing post-menopausal women: a six-month randomised, double-blinded and Placebo-Controlled trial.
    Liu ZM; Li G; Zhang D; Ho SC; Chen YM; Ma J; Huang Q; Li S; Ling WH
    Int J Food Sci Nutr; 2020 Aug; 71(5):644-652. PubMed ID: 31914834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of whole soy and isoflavones daidzein on bone turnover and inflammatory markers: a 6-month double-blind, randomized controlled trial in Chinese postmenopausal women who are equol producers.
    Liu ZM; Chen B; Li S; Li G; Zhang D; Ho SC; Chen YM; Ma J; Qi H; Ling WH
    Ther Adv Endocrinol Metab; 2020; 11():2042018820920555. PubMed ID: 32595918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 6-month effect of whole soy and purified isoflavones daidzein on thyroid function-A double-blind, randomized, placebo controlled trial among Chinese equol-producing postmenopausal women.
    Liu ZM; Zhang D; Li G; Ho SC; Chen YM; Ma J; Huang Q; Li S; Ling WH
    Phytother Res; 2021 Oct; 35(10):5838-5846. PubMed ID: 34494323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research protocol: effect of natural S-equol on blood pressure and vascular function--a six-month randomized controlled trial among equol non-producers of postmenopausal women with prehypertension or untreated stage 1 hypertension.
    Liu ZM; Ho SC; Chen YM; Xie YJ; Huang ZG; Ling WH
    BMC Complement Altern Med; 2016 Mar; 16():89. PubMed ID: 26928904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can soy intake affect serum uric acid level? Pooled analysis from two 6-month randomized controlled trials among Chinese postmenopausal women with prediabetes or prehypertension.
    Liu ZM; Ho CS; Chen YM; Woo J
    Eur J Nutr; 2015 Feb; 54(1):51-8. PubMed ID: 24659208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
    Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
    Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial.
    Mangano KM; Hutchins-Wiese HL; Kenny AM; Walsh SJ; Abourizk RH; Bruno RS; Lipcius R; Fall P; Kleppinger A; Kenyon-Pesce L; Prestwood KM; Kerstetter JE
    Nutr Res; 2013 Dec; 33(12):1026-33. PubMed ID: 24267042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
    Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
    Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
    Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
    Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoflavone supplement composition and equol producer status affect gene expression in adipose tissue: a double-blind, randomized, placebo-controlled crossover trial in postmenopausal women.
    van der Velpen V; Geelen A; Hollman PC; Schouten EG; van 't Veer P; Afman LA
    Am J Clin Nutr; 2014 Nov; 100(5):1269-77. PubMed ID: 25332325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of soy isoflavone supplementation on endothelial dysfunction and oxidative stress in equol-producing postmenopausal women.
    Pusparini ; Yenny ; Hidayat A
    Endocr Metab Immune Disord Drug Targets; 2015; 15(1):71-9. PubMed ID: 25441486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial.
    Hazim S; Curtis PJ; Schär MY; Ostertag LM; Kay CD; Minihane AM; Cassidy A
    Am J Clin Nutr; 2016 Mar; 103(3):694-702. PubMed ID: 26843154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment.
    van der Velpen V; Hollman PC; van Nielen M; Schouten EG; Mensink M; Van't Veer P; Geelen A
    Eur J Clin Nutr; 2014 Oct; 68(10):1141-7. PubMed ID: 24939433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Liu J; Woo J
    PLoS One; 2014; 9(2):e87861. PubMed ID: 24533060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bügel S; Koebnick C; Reimann M; Ferrari M; Branca F; Talbot D; Dadd T; Nilsson M; Dahlman-Wright K; Gustafsson JA; Minihane AM; Williams CM
    Am J Clin Nutr; 2005 Dec; 82(6):1260-8; quiz 1365-6. PubMed ID: 16332659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.